90-day mortality of severe sepsis and septic shock is reduced by initiation of oral beta-blocker therapy and increased by discontinuation of a pre-existing beta-blocker treatment

被引：0
|
作者：
C Fuchs
C Scheer
S Wauschkuhn
M Vollmer
S Rehberg
K Meissner
SO Kuhn
S Friesecke
P Abel
M Gründling
机构：
[1] Universitätsmedizin Greifswald,Klinik für Anästhesiologie
[2] Universitätsmedizin Greifswald,Klinik für Innere Medizin B
来源：
Intensive Care Medicine Experimental | / 3卷 / Suppl 1期
关键词：
Septic Shock; Severe Sepsis; Carvedilol; Sotalol; Esmolol;
D O I：
10.1186/2197-425X-3-S1-A88
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 24 条
  • [11] Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure
    Shakar, SF
    Abraham, WT
    Gilbert, EM
    Robertson, AD
    Lowes, BD
    Zisman, LS
    Ferguson, DA
    Bristow, MR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (06) : 1336 - 1340
  • [12] Successful treatment of severe adrenaline-resistant anaphylactic shock with glucagon in a patient taking a beta-blocker: a case report
    Yu Murakami
    Shohei Kaneko
    Haruka Yokoyama
    Hironori Ishizaki
    Motohiro Sekino
    Hiroaki Murata
    Tetsuya Hara
    JA Clinical Reports, 7
  • [13] Successful treatment of severe adrenaline-resistant anaphylactic shock with glucagon in a patient taking a beta-blocker: a case report
    Murakami, Yu
    Kaneko, Shohei
    Yokoyama, Haruka
    Ishizaki, Hironori
    Sekino, Motohiro
    Murata, Hiroaki
    Hara, Tetsuya
    JA CLINICAL REPORTS, 2021, 7 (01)
  • [14] PRE-ADMISSION BETA-BLOCKER USE AND 30-DAY MORTALITY AMONG PATIENTS IN INTENSIVE CARE: A COHORT STUDY
    Christensen, S.
    Johansen, M. B.
    Tonnesen, E.
    Larsson, A.
    Lemeshow, S.
    Pedersen, L.
    Sorensen, H. T.
    INTENSIVE CARE MEDICINE, 2010, 36 : S320 - S320
  • [15] Pre-operative beta-blocker therapy does not affect short-term mortality after esophageal resection for cancer
    Reda, Souheil
    Ahl, Rebecka
    Szabo, Eva
    Stenberg, Erik
    Forssten, Maximilian Peter
    Sjolin, Gabriel
    Cao, Yang
    Mohseni, Shahin
    BMC SURGERY, 2020, 20 (01)
  • [16] Pre-operative beta-blocker therapy does not affect short-term mortality after esophageal resection for cancer
    Souheil Reda
    Rebecka Ahl
    Eva Szabo
    Erik Stenberg
    Maximilian Peter Forssten
    Gabriel Sjolin
    Yang Cao
    Shahin Mohseni
    BMC Surgery, 20
  • [17] Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction
    Hioki, Hirofumi
    Motoki, Hirohiko
    Izawa, Atsushi
    Kashima, Yuichirou
    Miura, Takashi
    Ebisawa, Souichirou
    Tomita, Takeshi
    Miyashita, Yusuke
    Koyama, Jun
    Ikeda, Uichi
    HEART AND VESSELS, 2016, 31 (05) : 687 - 693
  • [18] Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction
    Hirofumi Hioki
    Hirohiko Motoki
    Atsushi Izawa
    Yuichirou Kashima
    Takashi Miura
    Souichirou Ebisawa
    Takeshi Tomita
    Yusuke Miyashita
    Jun Koyama
    Uichi Ikeda
    Heart and Vessels, 2016, 31 : 687 - 693
  • [19] Pre-admission beta-blocker use and 30-day mortality following intensive care: A population-based cohort study
    Christensen, Steffen
    Johansen, Martin B.
    Sorensen, Henrik T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S238 - S238
  • [20] The effect of pre-admission use of angiotensin converting enzyme inhibitor/angiotensin II receptor blocker and/or beta-blocker therapy on hospital acute decompensated heart failure hospital mortality
    Costanzo, MR
    Johannes, RS
    Gupta, V
    Saltzberg, M
    Suri, S
    Ashraf, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 86A - 86A
123